Fact checked byHeather Biele

Read more

April 13, 2023
2 min read
Save

Patients with rectal cancer report ‘good’ quality of life with watch-and-wait approach

Fact checked byHeather Biele
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Patients with rectal cancer who were observed by a watch-and-wait approach reported good quality of life.
  • Quality of life deteriorated in patients requiring surgery.

Patients with rectal cancer who were observed by a watch-and-wait approach reported “good” quality of life and less major bowel dysfunction than those requiring surgery, according to study results in JAMA Surgery.

“Patients observed by the watch-and-wait (WW) approach presumably have a better quality of life (QoL) and functional outcome because they do not require a definitive colostomy and have less surgery-related morbidity,” Petra A. Custers, MD, of the department of surgery at the Netherlands Cancer Institute, and colleagues wrote. “A small matched-controlled study revealed that patients observed by the WW approach scored better on several QoL domains and reported fewer bowel, urinary and sexual dysfunctions compared with patients after [total mesorectal excision]. Nevertheless, prospective long-term data on QoL and functional outcome after the WW approach are limited.”

diarrhea pain
Patients with rectal cancer who were observed by a watch-and-wait approach reported “good” quality of life and less major bowel dysfunction than those requiring surgery, according to study results in JAMA Surgery. Image: Adobe Stock

Using data from the Dutch Watch-and-Wait registry, researchers conducted two prospective cohort studies to assess long-term QoL and functional outcomes of 278 patients (median age, 66 years; 67% men) with rectal cancer and a clinical complete or near-complete response after neoadjuvant chemoradiotherapy or radiotherapy.

Researchers evaluated QoL at 3, 12 and 24 months after study inclusion using three European Organization for Research and Treatment of Cancer-Quality of Life questionnaires and a 36-item short-form health survey.

In the first 24 months, 80% of patients had sustained clinical complete response and were observed by a WW approach, 14% underwent total mesorectal excision (TME) and 6% underwent additional local excision.

Among WW patients, 25.3%, 24% and 24.9% reported major bowel dysfunction at 3, 12 and 24 months, respectively. Of 151 men in the WW group, 31.8% reported severe erectile dysfunction and 19.1% reported moderate urinary dysfunction at 24 months; women also reported decreased sexual satisfaction and function during follow-up.

Overall, though, “patients observed by the WW approach who did not require additional surgery reported good QoL, with limited variation over time,” researchers wrote.

Despite similar QoL scores, patients who underwent additional local excision reported more major bowel dysfunction (55.6%) compared with those who did not require additional surgery. Researchers noted those who underwent TME scored “significantly worse” on several QoL subscales.

“The data provided by the present study are essential for shared decision-making and for counseling patients on what to expect with the WW approach,” Custers and colleagues concluded. “With expanding treatment options available for patients with rectal cancer, making the optimal treatment decision for the individual patient is an increasingly challenging task. It requires a good understanding of all treatment options, including the associated oncologic outcome, as well as data on QoL and functional outcome.”